Coherus Biosciences Inc share price logo

Coherus Biosciences Inc Share Price

NASDAQ: CHRS

Small Cap

$1.73

+0.06

(+3.29%)

as on

Coherus Biosciences Inc Stock Performance

as on October 14, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $1.63
    $1.74
    downward going graph

    5.78%

    Downside

    0.58%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.66
    $2.43
    downward going graph

    61.83%

    Downside

    40.46%

    Upside

    downward going graph

Coherus Biosciences Inc share price movements today

Previous Close
$1.67
Open
$1.64
Volume
1.2M
Day's Low - High
$1.63 - $1.74
52 Week Low - High
$0.66 - $2.43

Coherus Biosciences Inc Historical Returns

1 Month Return
+ 34.11 %
3 Month Return
+ 82.16 %
1 Year Return
+ 84.22 %
3 Year Return
-79.11 %
5 Year Return
-90.54 %

Coherus Biosciences Inc Stock Fundamentals & Key Indicators

Check Coherus Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$194.1M

EPS (TTM)

-1.31

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.76%

PE Ratio (TTM)

3.15

Industry PE ratio

-0.32286624203821657

PEG Ratio

0

EBITDA

-83.8M

Revenue (TTM)

272.2M

Profit Margin

66.03%

Return On Equity TTM

33.11%

Coherus Biosciences Inc Stock Valuation

Track how Coherus Biosciences Inc P/E has moved over time to understand its valuation trends.

Coherus Biosciences Inc in the last 5 years

  • Overview

  • Trends

Lowest (-25.72x)

September 30, 2021

Industry (-0.32x)

October 14, 2025

Today (3.15x)

October 14, 2025

Highest (141.62x)

June 30, 2021

LowHigh

Today’s Price to Earnings Ratio: 3.15x

Coherus Biosciences Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Coherus Biosciences Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$194.1M-90.54%3.1566.03%
BUY$60.3B223.08%-505.15-12.96%
NA$37.8BNANA-3.89%
BUY$104.6B50.07%28.9831.86%
BUY$59.8B-7.17%14.2331.37%

Stock Returns calculator for Coherus Biosciences Inc Stock including INR - Dollar returns

The Coherus Biosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Coherus Biosciences Inc investment value today

Current value as on today

₹1,89,648

Returns

₹89,648

(+89.65%)

Returns from Coherus Biosciences Inc Stock

₹84,043 (+84.04%)

Dollar Returns*

₹5,606 (+5.61%)

Analyst Recommendation on Coherus Biosciences Inc Stock

Based on 16 analysts

BUY

81.25%

Buy

18.75%

Hold

0.00%

Sell

Based on 16 analysts, 81.25% of analysts recommend a 'BUY' rating for Coherus Biosciences Inc. Average target price of $5.67

Coherus Biosciences Inc Share Price Target

Get share price movements and forecasts by analysts on Coherus Biosciences Inc.

What analysts predicted

69.49%UPSIDE

Target Price

$5.67

Current Price

$1.73

Analyzed by

16 Analysts

Target

$5.67

Coherus Biosciences Inc target price $5.67, a slight upside of 69.49% compared to current price of $1.73. According to 16 analysts rating.

Coherus Biosciences Inc Stock’s Investor Sentiment and Interest

Search interest for Coherus Biosciences Inc Stock has increased by 148% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:148% versus previous 30 day period

Coherus Biosciences Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
32
58
74
91
2
64
70
54
7
10
Gross Profit
15
33
41
5
40
35
50
20
4
5
Operating Income
-67
-34
-32
-68
-42
-20
-6
-42
-45
-45
EBITDA
-65
-32
-28
-67
115
-6
-3
-44
-44
-45
Interest Expense
9
9
10
10
11
5
5
5
2
2
Depreciation
0
0
0
1
1
1
1
1
1
1
Income Before Tax
-75
-42
-40
-79
102
-12
-10
-50
-47
-44
Income Tax Expense
0
11
0
-10
1
-
-
-50
9
-342
Net Income
-74
-42
-39
-79
102
-12
-10
-50
-56
297
Net Profit Margin
-230.55%
-73.01%
-53.16%
-87.03%
4457.32%
-19.88%
-15.19%
-93.63%
-744.43%
2903.91%

Coherus Biosciences Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
30
190
1
1
356
475
326
211
257
266
Gross Profit
-182
-64
-158
-1
338
438
268
140
98
149
Operating Income
-219
-115
-232
-204
107
156
-263
-256
-203
-111
EBITDA
-222
-116
-225
-204
111
161
-260
-255
-193
60
Interest Expense
0
7
9
9
17
21
22
32
40
27
Depreciation
-
-
3
3
3
2
3
3
3
5
Income Before Tax
-223
-127
-238
-209
92
135
-287
-291
-238
28
Income Tax Expense
-7
0
9
4
2
3
19
34
0
28
Net Income
-223
-127
-238
-209
89
132
-287
-291
-237
28
Net Profit Margin
-743.18%
-66.98%
-15306.56%
-13453.66%
25.23%
27.79%
-87.92%
-138.24%
-92.48%
10.68%

Coherus Biosciences Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-42
-39
-79
102
-12
-10
-50
-56
297
Operating Cash Flow
-38
-54
-12
-46
59
-62
28
-25
-46
Investing Cash Flow
41
50
35
202
27
0
0
-17
462
Financing Cash Flow
54
11
0
0
-187
0
0
0
-281
Change in Cash
56
7
22
156
-100
-61
28
-43
134

Coherus Biosciences Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-127
-238
-209
89
132
-287
-291
-237
28
Operating Cash Flow
-252
-200
-159
28
154
-37
-241
-174
-20
Investing Cash Flow
-6
-4
-1
-12
-14
-138
-166
144
230
Financing Cash Flow
226
206
105
89
223
51
54
69
-186
Change in Cash
-33
1
-54
104
363
-123
-353
39
22

Global Institutional Holdings in Coherus Biosciences Inc

Funds
Holdings
BlackRock Inc
9.24%
Vanguard Group Inc
9.09%
TANG CAPITAL MANAGEMENT LLC
4.39%
Kohlberg Kravis Roberts & Co LP
2.61%
Geode Capital Management, LLC
2.3%

Insights on Coherus Biosciences Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 7.59M → 10.25M (in $), with an average increase of 25.9% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -56.56M → 297.76M (in $), with an average increase of 119.0% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, CHRS stock has moved up by 29.5%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, CHRS has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 148.2% return, outperforming this stock by 228.0%

About Coherus Biosciences Inc

coherus biosciences is the leading biologics platform company solely focused on delivering high-quality biosimilar therapeutics that will expand patient access to life-changing medicines in regulated markets worldwide. founded in 2010, coherus is a late-stage biologics platform company focused on the global biosimilar market. headquartered in the san francisco bay area and composed of a team of industry veterans with decades of experience in pioneering biologics companies, our goal is to become a global leader in the biosimilar market by leveraging our team's collective expertise in key areas such as process science, analytical characterization, protein production and clinical-regulatory development. our commercialization partnerships include global pharmaceutical companies in europe, asia and latin america. biosimilars are intended for use in place of existing, branded biologics to treat a range of chronic and often life-threatening diseases, with the potential to reduce costs and exp
OrganisationCoherus Biosciences Inc
Headquarters333 Twin Dolphin Drive, Redwood City, CA, United States, 94065
IndustryHealth Technology
CEOMr. Dennis M. Lanfear
E-voting on sharesClick here to vote

Key Management of Coherus Biosciences Inc

Name

Title

Mr. Dennis M. Lanfear

Chairman, President & CEO

Mr. Bryan J. McMichael

Chief Financial Officer

Mr. Scott Saywell

Executive Vice President of Corporate Development

Mr. Michael Chen

Senior Vice President of Commercial Analytics & Trade

Ms. Jodi Sievers

Vice President of Investor Relations & Corporate Communications

Mr. Andy Rittenberg

Executive Vice President of General Counsel

Ms. Rebecca Sunshine

Chief Human Resources Officer

Dr. Theresa M. Lavallee Ph.D.

Chief Development Officer & Chairman of Scientific Advisory Board

Dr. Rosh Dias M.D., MRCP

Chief Medical Officer

FAQs

What is Coherus Biosciences Inc share price today?

Coherus Biosciences Inc share price today is $1.73 as on at the close of the market. Coherus Biosciences Inc share today touched a day high of $1.74 and a low of $1.63.

What is the 52 week high and 52 week low for Coherus Biosciences Inc share?

Coherus Biosciences Inc share touched a 52 week high of $2.43 on and a 52 week low of $0.66 on . Coherus Biosciences Inc stock price today i.e. is closed at $1.73,which is 28.81% down from its 52 week high and 162.00% up from its 52 week low.

What is Coherus Biosciences Inc's market capitalisation today?

Coherus Biosciences Inc market capitalisation is $0.00T as on .

How to invest in Coherus Biosciences Inc Stock (CHRS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Coherus Biosciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Coherus Biosciences Inc Shares that will get you 0.8671 shares as per Coherus Biosciences Inc share price of $1.73 per share as on October 14, 2025 at 1:29 am IST.

What is the minimum amount required to buy Coherus Biosciences Inc Stock (CHRS) from India?

Indian investors can start investing in Coherus Biosciences Inc (CHRS) shares with as little as ₹88.635 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.35 in Coherus Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Coherus Biosciences Inc share’s latest price of $1.73 as on October 14, 2025 at 1:29 am IST, you will get 5.7803 shares of Coherus Biosciences Inc. Learn more about fractional shares .

What are the returns that Coherus Biosciences Inc has given to Indian investors in the last 5 years?

Coherus Biosciences Inc stock has given -90.54% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?